Tender: Oblitoxaximab Injection Procurement for Inhalation Anthrax – Public Health Agency of Canada

Released 1 day ago

Closes08 Dec 2026
Likely valueEstimate$7.0M to $92.0M
LocationCanada
SourceCanadaBuys
CategoryHealth & Medical
ReferenceWS5994329939
19 days leftCloses Tue, 8 Dec 2026

Public Health Agency of Canada is seeking a supplier for Oblitoxaximab injection, an antitoxin used to treat inhalation anthrax. Public Services and Procurement Canada has issued an Advanced Contract Award Notice proposing to negotiate a contract with Elusys Therapeutics, Inc on behalf of PHAC and invites other suppliers to submit a statement of capabilities by the ACAN closing date so they can be considered; if no supplier meets the ACAN requirements by that date, the contracting officer may proceed with award to the pre-identified supplier.

Similar open tenders5

Similar awarded contracts4

Likely value $7.0M to $92.0M

Agency spend history

Public Services and Procurement Canada

What Public Services and Procurement Canada has spent, year by year and by contract size, and who won the work.

GovMarket

We do the hard work.
You win the work.

We find the tenders, read the documents and track who wins, so your time goes on bids you can win.

–open health and medical tenders right now
–new in the last 7 days
–contracts awarded in the last 12 months
7 days free, then $59/CAD per month